Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  CompuGroup Medical Societas Europaea    COP   DE0005437305

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

CompuGroup Medical Societas Europaea : to acquire certain Cerner assets in Germany and Spain

share with twitter share with LinkedIn share with facebook
share via e-mail
02/05/2020 | 05:36am EDT
  • Acquisition of medico®, Soarian Health Archive® (S-HA) and Soarian® Integrated Care (S-IC), leading hospital information systems (HIS) in Germany, and of Selene®, a leading HIS in Spain, from Cerner
  • Strengthening CompuGroup Medical's position in Germany and expanding the portfolio in Spain
  • CompuGroup Medical addressing complementary customer groups and building an attractive platform for future growth

CompuGroup Medical SE (CGM) and Cerner Corporation (NASDAQ: CERN), a global health care technology company, have entered into an agreement regarding the acquisition by CompuGroup Medical of a part of Cerner's portfolio in Germany and Spain. The key products are medico® and Soarian® Integrated Care (S-IC), leading HISs in Germany; Selene®, a leading HIS for public hospitals in Spain, and Soarian Health Archive®, a document archiving solution for healthcare providers. As a result of the acquisition, CompuGroup Medical is strengthening its position in Germany and complementing its portfolio in Spain. The agreed purchase price amounts to EUR 225 million and is subject to final adjustment upon closing. For 2019, revenues attributable to the assets to be purchased were approximately EUR 74 million with an EBITDA of approximately EUR 13 million.

'The products from this acquisition are an excellent fit with our current portfolio,' emphasizes Frank Gotthardt, Chairman and CEO of CompuGroup Medical SE. 'Existing customers of CGM as well as those of medico, S-IC, S-HA and Selene will benefit from this transaction: The products acquired from Cerner complement our existing portfolio of products perfectly, and we believe the exchange between professionals of all healthcare segments will be further intensified. For all of our customers, this means that they will be optimally prepared for a world in which the patient journey is increasingly cross-institutional and cross-sectoral. And this is true regardless of whether they are doctors' or dentists' practices, hospitals, laboratories, pharmacies, rehabilitation or care facilities or other service providers.'

'With this acquisition, we will increase our installed customer base in the hospital information system market. At the same time, we will benefit from a great amount of know-how and expert knowledge from our new colleagues. We are convinced that by combining medico and Selene with the CGM connectivity services and our innovative CGM CLINICAL modules we will be able to generate high and long-term added value for our customers in the future,' says Hannes Reichl, CGM Board Member Clinical and Social Care.

Cerner has embarked on a company-wide transformation focused on improved operating efficiencies, enhanced client focus, a refined growth strategy and a sharpened approach to portfolio management. The sale of these German and Spanish solutions to CompuGroup Medical are reflective of Cerner's active portfolio management. Barclays acted as exclusive financial advisor to Cerner.

'Most importantly, we believe this is positive for Cerner customers,' said Emil Peters, President, Cerner Global. 'CompuGroup Medical is a leading, global health-IT company and has a strong customer-centric focus. While we refine our strategic focus and align around Cerner's core global assets, we believe clients transitioning to CompuGroup Medical will be in very good hands.'

The customer base of the medico product today consists of 251 hospitals in Germany and the customer base of the Selene product consists of 65 hospitals in Spain. Today, more than one million professional users, including doctors, dentists, pharmacies and other health professionals in outpatient and inpatient health care facilities trust CompuGroup Medical.

Michael Rauch, CGM's CFO, comments: 'This transaction is further enhancing our HIS segment and hence reinforcing our business profile of connecting all health care professionals. The acquisition is EPS accretive to CompuGroup Medical in year one on a pro forma basis and strengthens the cash flow profile of CompuGroup Medical.'

Closing of the transaction is expected to occur in the third quarter of 2020, subject to certain regulatory approvals and other closing conditions.

Disclaimer

CompuGroup Medical SE published this content on 05 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 February 2020 10:35:02 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on COMPUGROUP MEDICAL SOCIETA
05/14COMPUGROUP MEDICAL SOCIETAS EUROPAEA : Ex-dividend day for final dividend
FA
05/13COMPUGROUP MEDICAL SE : Annual General Meeting approves change of legal form int..
EQ
05/13COMPUGROUP MEDICAL SE : Annual General Meeting approves the change of legal form..
EQ
05/12COMPUGROUP MEDICAL : Baader Bank downgrades from Buy to Sell
MD
05/12COMPUGROUP MEDICAL : Berenberg gives a Neutral rating
MD
05/07COMPUGROUP MEDICAL : Warburg Research reiterates its Buy rating
MD
05/07COMPUGROUP MEDICAL : Baader Bank keeps its Buy rating
MD
05/07COMPUGROUP MEDICAL SOCIETAS EUROPAEA : Quarterly Statement Q1 2020
PU
05/07COMPUGROUP MEDICAL SOCIETAS EUROPAEA : with a strong start to the year
EQ
04/29COMPUGROUP MEDICAL SE : Preliminary announcement of the publication of quarterly..
EQ
More news
Financials (EUR)
Sales 2020 786 M
EBIT 2020 143 M
Net income 2020 90,1 M
Debt 2020 567 M
Yield 2020 0,77%
P/E ratio 2020 39,1x
P/E ratio 2021 35,3x
EV / Sales2020 5,19x
EV / Sales2021 4,62x
Capitalization 3 510 M
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COMPUGROUP MEDICAL SOCIETA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 74,50 €
Last Close Price 72,50 €
Spread / Highest target 10,3%
Spread / Average Target 2,76%
Spread / Lowest Target -7,59%
EPS Revisions
Managers
NameTitle
Frank Gotthardt Chairman-Management Board & CEO
Klaus Esser Chairman-Supervisory Board
Michael Rauch Chief Financial Officer
Hannes Reichl Director-Clinical & Social Care
Daniel Gotthardt Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA13.73%3 856
ORACLE CORPORATION-0.68%166 446
SAP SE-7.76%145 180
INTUIT INC.7.74%73 560
SERVICENOW INC.34.84%72 595
CONSTELLATION SOFTWARE INC.26.94%24 441